This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 22-25, 2026
Hynes Convention CenterBoston, USA
Book Now
Menu
Book
Key Sessions
Andrea Little
KEYNOTE: Engineering ADC Success from the Start: The Critical Role of Cell Culture
Pfizer
Jared Auclair, PhD
KEYNOTE: Biopharmaceutical Characterization in the Age of Artificial Intelligence: From Data to Decision
Northeastern University
Nelly Viseux
Keynote: Journey from R&D to Clinical Manufacturing
Regeneron
Robert Hofmeister
Keynote: Programming Immunity In Vivo: Targeted RNA–LNP Platforms for Precision CAR Engineering
CREATE Medicines
keyboard_arrow_right

Friday 25th September - Main Conference Day Three - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Friday 25th September - Main Conference Day Three - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
8:50am - 9:00am
Chairperson
9:00am - 9:30am
Fireside Chat: New Modalities, Old Playbook: Are Multispecifics and Gene Therapy Cell Lines Stuck in mAb Thinking?
  • Yifeng Xu - Principal Scientist, Pfizer
9:30am - 10:00am
Rational Vector Design and Screening Strategies for Bispecific Cell Line Development via Random Integration
  • Paul Rousseau - Sr. Engineer II, Cell Line Development, Biogen
10:00am - 10:30am
Sponsored Presentation
Showing 1 of 1 Streams
11:15am - 11:45am
Right-First-Time Cell Line Development: Speed, Productivity, and Quality by Design
  • Yizhou Zhou - Director, Cell Line Development & Engineering, Bristol-Myers Squibb
11:45am - 12:15pm
Rebuilding CLD Without Legacy Constraints: A Strategy- and Data-Driven Case Study
  • Sowmya Balasubramanian - Associate Director, Cell Line Development, Gilead Sciences
12:15pm - 12:45pm
Sponsored Presentation
Showing 1 of 1 Streams
2:00pm - 2:30pm
Causal intelligence through multiplex cell line engineering
  • Stefan Schmidt - Advisor, Optigenomics Ltd
2:30pm - 3:30pm
PANEL DISCUSSION: Precision Cell Line Engineering for Biologics: Focused Innovations and Applications
  • Stefan Schmidt - Advisor, Optigenomics Ltd
  • Yifeng Xu - Principal Scientist, Pfizer
Thursday 24th September - Main Conference Day Two
Filter
Streams
Clear
Choose Day